Efficacy of cenobamate by focal seizure subtypes: Post-hoc analysis of a phase 3, multicenter, open-label study

Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open‐label study

(2021) Michael R. Sperling et al.   EPILEPSIA

Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open‐label safety study

(2020) Michael R. Sperling et al.   EPILEPSIA

Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures

(2020) Steve S. Chung et al.   NEUROLOGY

Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial

(2019) Gregory L Krauss et al.   LANCET NEUROLOGY

Clinical risk factors in SUDEP

(2019) Olafur Sveinsson et al.   NEUROLOGY

Initial Management of Epilepsy

(2008) Jacqueline A. French et al.   NEW ENGLAND JOURNAL OF MEDICINE